NOT FOR DISTRIBUTION
Header cover image

UMP Healthcare Holdings

Market Cap

HK$621.0m

Last Updated

2021/04/19 10:23 UTC

Data Sources

Company Financials

Executive Summary

UMP Healthcare Holdings Limited, an investment holding company, provides a range of medical and healthcare services in the People’s Republic of China. More Details


Snowflake Analysis

Flawless balance sheet and slightly overvalued.

Share Price & News

How has UMP Healthcare Holdings's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: 722 is not significantly more volatile than the rest of Hong Kong stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: 722's weekly volatility (5%) has been stable over the past year.


Market Performance


7 Day Return

1.2%

722

3.5%

HK Healthcare

0.7%

HK Market


1 Year Return

-33.3%

722

28.5%

HK Healthcare

28.1%

HK Market

Return vs Industry: 722 underperformed the Hong Kong Healthcare industry which returned 28.5% over the past year.

Return vs Market: 722 underperformed the Hong Kong Market which returned 28.1% over the past year.


Shareholder returns

722IndustryMarket
7 Day1.2%3.5%0.7%
30 Day-3.5%12.3%-0.2%
90 Day-28.7%14.4%0.2%
1 Year-31.2%-33.3%31.7%28.5%33.4%28.1%
3 Year-48.8%-52.3%-34.0%-38.3%8.1%-3.8%
5 Year-32.5%-39.3%-35.3%-41.3%56.5%28.9%

Long-Term Price Volatility Vs. Market

How volatile is UMP Healthcare Holdings's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is UMP Healthcare Holdings undervalued compared to its fair value and its price relative to the market?

13.99x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: 722 (HK$0.82) is trading above our estimate of fair value (HK$0.49)

Significantly Below Fair Value: 722 is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: 722 is good value based on its PE Ratio (14x) compared to the HK Healthcare industry average (20.7x).

PE vs Market: 722 is poor value based on its PE Ratio (14x) compared to the Hong Kong market (11.8x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate 722's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: 722 is good value based on its PB Ratio (1x) compared to the HK Healthcare industry average (1.3x).


Future Growth

How is UMP Healthcare Holdings forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

19.3%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as UMP Healthcare Holdings has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has UMP Healthcare Holdings performed over the past 5 years?

22.8%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: 722 has high quality earnings.

Growing Profit Margin: 722's current net profit margins (8%) are lower than last year (12.2%).


Past Earnings Growth Analysis

Earnings Trend: 722's earnings have grown significantly by 22.8% per year over the past 5 years.

Accelerating Growth: 722's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 722 had negative earnings growth (-40.6%) over the past year, making it difficult to compare to the Healthcare industry average (1%).


Return on Equity

High ROE: 722's Return on Equity (6.4%) is considered low.


Financial Health

How is UMP Healthcare Holdings's financial position?


Financial Position Analysis

Short Term Liabilities: 722's short term assets (HK$406.5M) exceed its short term liabilities (HK$204.2M).

Long Term Liabilities: 722's short term assets (HK$406.5M) exceed its long term liabilities (HK$49.2M).


Debt to Equity History and Analysis

Debt Level: 722 is debt free.

Reducing Debt: 722 has not had any debt for past 5 years.

Debt Coverage: 722 has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: 722 has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Dividend

What is UMP Healthcare Holdings's current dividend yield, its reliability and sustainability?

4.02%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: 722's dividend (4.02%) is higher than the bottom 25% of dividend payers in the Hong Kong market (1.95%).

High Dividend: 722's dividend (4.02%) is low compared to the top 25% of dividend payers in the Hong Kong market (5.98%).


Stability and Growth of Payments

Stable Dividend: 722 has been paying a dividend for less than 10 years and during this time payments have been volatile.

Growing Dividend: 722's dividend payments have increased, but the company has only paid a dividend for 5 years.


Current Payout to Shareholders

Dividend Coverage: With its reasonable payout ratio (62.3%), 722's dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

5.7yrs

Average management tenure


CEO

Yiu Kwong Sun (77 yo)

5.67yrs

Tenure

HK$8,140,000

Compensation

Dr. Yiu Kwong Sun has been Chief Executive Officer at UMP Healthcare Holdings Limited since August 29, 2015 and serves as its Chairman. Dr. Sun has been Executive Director of UMP Healthcare Holdings sine A...


CEO Compensation Analysis

Compensation vs Market: Yiu Kwong's total compensation ($USD1.05M) is above average for companies of similar size in the Hong Kong market ($USD227.85K).

Compensation vs Earnings: Yiu Kwong's compensation has been consistent with company performance over the past year.


Leadership Team

Experienced Management: 722's management team is seasoned and experienced (5.7 years average tenure).


Board Members

Experienced Board: 722's board of directors are considered experienced (5.4 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: 722 insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

UMP Healthcare Holdings Limited's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: UMP Healthcare Holdings Limited
  • Ticker: 722
  • Exchange: SEHK
  • Founded: 1990
  • Industry: Health Care Facilities
  • Sector: Healthcare
  • Market Cap: HK$621.003m
  • Shares outstanding: 766.67m
  • Website: https://www2.ump.com.hk

Number of Employees


Location

  • UMP Healthcare Holdings Limited
  • Wing On House
  • Room 1404–1408
  • Central
  • Hong Kong

Listings


Biography

UMP Healthcare Holdings Limited, an investment holding company, provides a range of medical and healthcare services in the People’s Republic of China. It operates through two segments, Corporate Healthcare...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/04/19 10:23
End of Day Share Price2021/04/19 00:00
Earnings2020/12/31
Annual Earnings2020/06/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.